SMEs (small and medium-sized enterprises) see benefit from UK Patents Bill:
This article was originally published in Clinica
Executive Summary
The UK Patents Bill was passed by parliament on July 14, at the third reading. It incorporates a clause (amending section 106 of the Patents Act 1977) that aims to "make a small additional improvement to the framework for enforcement of patent rights" and an amendment which seek to address the concerns particularly of small and medium-sized enterprises (SMEs). The changes "aim to help SMEs in appropriate circumstances where they face litigation in the courts", taking into account the need for the framework to be "accessible to an SME patent holder, but which is also fair to a party against whom enforcement action may be taken, [which] may be another SME".
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.